Fulcrum Capital’s Thermo Fisher Scientific TMO Stock Holding History

Fulcrum Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.55M	Buy	+7,086	New	+$3.4M	0.72%	34
2025 Q1	–	Sell	-760	Closed	-$395K	–	120
2024 Q4	$395K	Hold	760	–	–	0.08%	77
2024 Q3	$470K	Hold	760	–	–	0.1%	71
2024 Q2	$420K	Hold	760	–	–	0.1%	73
2024 Q1	$442K	Hold	760	–	–	0.1%	73
2023 Q4	$403K	Hold	760	–	–	0.1%	76
2023 Q3	$385K	Sell	760 -126	-14%	-$67.1K	0.11%	70
2023 Q2	$462K	Hold	886	–	–	0.12%	69
2023 Q1	$511K	Buy	+886	New	+$499K	0.14%	67

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Fulcrum Capital's TMO Position: Q2 2026 in Review

Fulcrum Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 7,086 shares worth $3.55M. The stake represents 0.72% of the portfolio and ranks #34 among its holdings. This is a return to the name: Fulcrum Capital previously reported a position in TMO as recently as Q4 2024.

Fulcrum Capital first reported a position in TMO in Q1 2023 and has held it in 9 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Fulcrum Capital held 7,086 shares of Thermo Fisher Scientific worth $3.55M as of Q2 2026.
Thermo Fisher Scientific was a new Fulcrum Capital position in Q2 2026.
Thermo Fisher Scientific made up 0.72% of Fulcrum Capital's portfolio in Q2 2026, its #34 holding.
Fulcrum Capital first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 9 quarters since.
794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fulcrum Capital's 13F filing for Q2 2026, filed 21 Jul 2026.